| scholarly article | Q13442814 |
| P50 | author | Kobporn Boonnak | Q56411904 |
| P2093 | author name string | Boonrat Tassaneetrithep | |
| Mary A Marovich | |||
| Gina C Donofrio | |||
| Kaitlyn M Dambach | |||
| P2860 | cites work | The two faces of interleukin 10 in human infectious diseases | Q36576509 |
| Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I | Q36851783 | ||
| Vaccine-induced enhancement of viral infections. | Q37330748 | ||
| Cytokine and cytokine receptor gene polymorphisms and their functionality. | Q37336228 | ||
| Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America | Q39240429 | ||
| IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba | Q39372304 | ||
| Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells | Q40179370 | ||
| Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection | Q40379127 | ||
| Dengue and hemorrhagic fever: a potential threat to public health in the United States | Q40429888 | ||
| Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells | Q40433630 | ||
| Infection of human primary hepatocytes with dengue virus serotype 2. | Q40459421 | ||
| Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients | Q40488945 | ||
| Differential effects of dengue virus on infected and bystander dendritic cells | Q40516020 | ||
| Human dendritic cells as targets of dengue virus infection | Q40585577 | ||
| Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism | Q40593854 | ||
| Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity | Q40632182 | ||
| Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors | Q40743557 | ||
| Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection | Q40763034 | ||
| Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation | Q40820410 | ||
| Comparison of P388D1 mouse macrophage cell line and human monocytes for assay of dengue-2 infection-enhancing antibodies | Q40839160 | ||
| Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages | Q41912620 | ||
| Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells | Q43446337 | ||
| Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection | Q45722071 | ||
| Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus | Q45731250 | ||
| An investigation of polymorphism in the interleukin-10 gene promoter | Q48054541 | ||
| Effect of interleukin-10 on dendritic cell maturation and function | Q73396250 | ||
| Genetic influence on cytokine production in meningococcal disease | Q73499262 | ||
| Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression | Q73850215 | ||
| Induction of tolerance by IL-10-treated dendritic cells | Q73873437 | ||
| Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo | Q78446243 | ||
| The mannose receptor mediates dengue virus infection of macrophages | Q21090526 | ||
| Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses | Q24536024 | ||
| Role of dendritic cells in antibody-dependent enhancement of dengue virus infection | Q24655655 | ||
| DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells | Q24673466 | ||
| New mouse model for dengue virus vaccine testing | Q27469339 | ||
| Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection. | Q27470004 | ||
| Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus | Q27472728 | ||
| Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody | Q27485050 | ||
| Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever | Q27486912 | ||
| How cells respond to interferons | Q27861006 | ||
| Cross-reacting antibodies enhance dengue virus infection in humans | Q28281588 | ||
| Type I interferons in host defense | Q29615912 | ||
| Neutralization and antibody-dependent enhancement of dengue viruses | Q29618172 | ||
| Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever | Q29619530 | ||
| Human skin Langerhans cells are targets of dengue virus infection | Q29619564 | ||
| Antiviral defense: interferons and beyond | Q33252389 | ||
| Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles | Q33358547 | ||
| Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever | Q33371648 | ||
| Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells. | Q33381253 | ||
| Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors | Q33947431 | ||
| Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis | Q33949186 | ||
| Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development | Q34136494 | ||
| Hijacking and exploitation of IL-10 by intracellular pathogens | Q34137986 | ||
| Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. | Q34315016 | ||
| Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell | Q34424960 | ||
| Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. | Q35845894 | ||
| IL-10 gene polymorphisms in infectious disease and SIDS. | Q35869200 | ||
| Selective suppression of interleukin-12 induction after macrophage receptor ligation | Q36377302 | ||
| Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical | Q36510607 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| Dengue virus | Q476209 | ||
| P304 | page(s) | 1671-1683 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection | |
| P478 | volume | 85 |
| Q35716620 | A three-component biomarker panel for prediction of dengue hemorrhagic fever. |
| Q34353489 | An emerging role for the anti-inflammatory cytokine interleukin-10 in dengue virus infection. |
| Q25708015 | Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses |
| Q59354500 | Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors |
| Q36628520 | Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy |
| Q40142039 | Antibody-enhanced dengue disease generates a marked CNS inflammatory response in the black-tufted marmoset Callithrix penicillata |
| Q34500247 | Cellular and cytokine correlates of severe dengue infection |
| Q27468886 | Challenges to the Design of Clinical Trials for Live-Attenuated Tetravalent Dengue Vaccines |
| Q91807708 | Considering Genomic and Immunological Correlates of Protection for a Dengue Intervention |
| Q28085328 | Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity |
| Q40088326 | Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity. |
| Q36085940 | Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials |
| Q21131391 | DENV inhibits type I IFN production in infected cells by cleaving human STING |
| Q66679529 | Dengue Virus Infection of Blood-Brain Barrier Cells: Consequences of Severe Disease |
| Q56343523 | Dengue immune sera enhance Zika virus infection in human peripheral blood monocytes through Fc gamma receptors |
| Q92397008 | Dengue infection and advances in dengue vaccines for children |
| Q40111176 | Dengue tropism for macrophages and dendritic cells: the host cell effect |
| Q34364315 | Dengue virus infection mediates HMGB1 release from monocytes involving PCAF acetylase complex and induces vascular leakage in endothelial cells |
| Q34184747 | Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells |
| Q34746693 | Dengue virus neutralization in cells expressing Fc gamma receptors |
| Q35119732 | Dengue virus type 2 (DENV2)-induced oxidative responses in monocytes from glucose-6-phosphate dehydrogenase (G6PD)-deficient and G6PD normal subjects |
| Q35294150 | Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera |
| Q34613581 | Differential expression of Toll-like receptors in dendritic cells of patients with dengue during early and late acute phases of the disease |
| Q38887040 | Early dengue virus interactions: the role of dendritic cells during infection |
| Q41933559 | Enhancement of Zika Infection by Dengue Virus-Specific Antibody Is Associated With Low Levels of Antiviral Factors |
| Q40261835 | Environmental influences on antibody-enhanced dengue disease outcomes. |
| Q40244711 | Evaluation and analysis of dengue virus enhancing and neutralizing activities using simple high-throughput assays |
| Q33609685 | Evasion of the human innate immune system by dengue virus |
| Q38615396 | Fc receptors in antibody-dependent enhancement of viral infections |
| Q24737461 | Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex |
| Q57491430 | Flavivirus Receptors: Diversity, Identity, and Cell Entry |
| Q56877965 | Flaviviruses and Autophagy |
| Q27322804 | Hierarchical Cluster Analysis of Three-Dimensional Reconstructions of Unbiased Sampled Microglia Shows not Continuous Morphological Changes from Stage 1 to 2 after Multiple Dengue Infections in Callithrix penicillata |
| Q93140606 | Hijacking the Host Immune Cells by Dengue Virus: Molecular Interplay of Receptors and Dengue Virus Envelope |
| Q30235062 | Host-Virus Interaction of ZIKA Virus in Modulating Disease Pathogenesis |
| Q36862433 | Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection |
| Q42373352 | IFNγ Enhances CD64-Potentiated Phagocytosis of Treponema pallidum Opsonized with Human Syphilitic Serum by Human Macrophages |
| Q35179653 | Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN. |
| Q39236667 | Immune-mediated cytokine storm and its role in severe dengue |
| Q37901360 | Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms |
| Q92239353 | Impaired production of immune mediators in dengue virus type 2-infected mononuclear cells of adults with end stage renal disease |
| Q34502717 | Induction of IFNα or IL-12 depends on differentiation of THP-1 cells in dengue infections without and with antibody enhancement |
| Q90462841 | Insights from direct studies on human dengue infections |
| Q39041179 | Meta-Analysis of the Relationship between TNF-α (-308G/A) and IL-10 (-819C/T) Gene Polymorphisms and Susceptibility to Dengue |
| Q54217627 | Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent Enhancement and Strategies to Protect Against Enhancement in Zika Virus Infection. |
| Q35138665 | Molecular classification of outcomes from dengue virus -3 infections |
| Q38045381 | Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans |
| Q33401149 | Mosquito bite delivery of dengue virus enhances immunogenicity and pathogenesis in humanized mice |
| Q93140850 | No Evidence for a Role for Antibodies during Vaccination-Induced Enhancement of Porcine Reproductive and Respiratory Syndrome |
| Q45740034 | Non-neutralizing antibodies protect from chronic LCMV infection independently of activating FcγR or complement |
| Q26766198 | Pathogenesis of Dengue: Dawn of a New Era |
| Q40078229 | Plant-produced anti-dengue virus monoclonal antibodies exhibit reduced antibody-dependent enhancement of infection activity. |
| Q40122055 | Polymorphisms of Transporter Associated with Antigen Presentation, Tumor Necrosis Factor-α and Interleukin-10 and their Implications for Protection and Susceptibility to Severe Forms of Dengue Fever in Patients in Sri Lanka |
| Q92859173 | Recent advances in understanding dengue |
| Q92471671 | Reciprocal immune enhancement of dengue and Zika virus infection in human skin |
| Q40135638 | Secondary Dengue Virus infections during the 2009 outbreak in Buenos Aires |
| Q40039463 | Soluble Fas Ligand as a Potential Marker of Severity of Dengue Infection |
| Q33414560 | Subversion of early innate antiviral responses during antibody-dependent enhancement of Dengue virus infection induces severe disease in immunocompetent mice |
| Q24288867 | Tackling dengue fever: Current status and challenges |
| Q36978907 | The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability |
| Q52345950 | The expression profile of human peripheral blood mononuclear cell miRNA is altered by antibody-dependent enhancement of infection with dengue virus serotype 3. |
| Q37987124 | The human antibody response to dengue virus infection |
| Q36612659 | The importance of hematopoietic progenitor cells in dengue. |
| Q60046445 | Viral-Induced Enhanced Disease Illness |
| Q91292204 | [1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation |
Search more.